Post by
rixpix on Jan 18, 2022 8:36am
And today we're mentioned in the Globe and Mail
The Globe's David Leeder writes that Ms. Stellick set a share target of $3. GL.
Comment by
Stockfshr on Jan 18, 2022 8:49am
Yes. Love that the Globe reused the word "blockbuster" from Chelsea's report. "Ms. Stellick thinks Sernova possesses "blockbuster potential to establish a new standard of care for diabetes treatment and apply its platform to other chronic diseases using several complementary technologies."
Comment by
BioTeck on Jan 18, 2022 9:15am
Blockbuster is synonymous with bankrupt haha. I can still see that ugly blue and yellow logo.
Comment by
Stockfshr on Jan 18, 2022 11:15am
How about the word "disruptive", BioTeck? I love that word too! Blockbuster + disruptive = profits!
Comment by
BioTeck on Jan 18, 2022 4:09pm
Another disruptive day. With the lack of a blockbuster deal we continue to trickle back to 1.20. If management is sitting on any news. Now is the time to release it. Actually let's wait for another conference, that seems to always work.
Comment by
Stockfshr on Jan 18, 2022 4:25pm
Don't worry. We will definitely rally from these or lower levels! :)
Comment by
Ekenbullets on Jan 19, 2022 7:29am
Didnt Charly say deal in september? Perhaps it was 2022...
Comment by
Charly50 on Jan 19, 2022 8:05am
View PT's original email again......
Comment by
Metalsguy1 on Jan 19, 2022 1:04pm
Frauulein smokes a lot of crack. I would not rely on her predictions.
Comment by
Charly50 on Jan 18, 2022 9:37am
good this form of media coverage!!! The right way....